1. Home
  2. ARIS vs LQDA Comparison

ARIS vs LQDA Comparison

Compare ARIS & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARIS
  • LQDA
  • Stock Information
  • Founded
  • ARIS 2015
  • LQDA 2004
  • Country
  • ARIS United States
  • LQDA United States
  • Employees
  • ARIS N/A
  • LQDA N/A
  • Industry
  • ARIS Water Supply
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARIS Utilities
  • LQDA Health Care
  • Exchange
  • ARIS Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • ARIS 823.8M
  • LQDA 957.2M
  • IPO Year
  • ARIS 2021
  • LQDA 2018
  • Fundamental
  • Price
  • ARIS $24.69
  • LQDA $12.29
  • Analyst Decision
  • ARIS Buy
  • LQDA Strong Buy
  • Analyst Count
  • ARIS 6
  • LQDA 7
  • Target Price
  • ARIS $24.83
  • LQDA $26.67
  • AVG Volume (30 Days)
  • ARIS 485.6K
  • LQDA 778.3K
  • Earning Date
  • ARIS 02-26-2025
  • LQDA 11-13-2024
  • Dividend Yield
  • ARIS 1.64%
  • LQDA N/A
  • EPS Growth
  • ARIS 67.78
  • LQDA N/A
  • EPS
  • ARIS 0.81
  • LQDA N/A
  • Revenue
  • ARIS $420,960,000.00
  • LQDA $15,610,000.00
  • Revenue This Year
  • ARIS $10.66
  • LQDA N/A
  • Revenue Next Year
  • ARIS $7.92
  • LQDA $209.63
  • P/E Ratio
  • ARIS $30.53
  • LQDA N/A
  • Revenue Growth
  • ARIS 13.51
  • LQDA N/A
  • 52 Week Low
  • ARIS $7.74
  • LQDA $8.26
  • 52 Week High
  • ARIS $27.94
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • ARIS 51.16
  • LQDA 66.36
  • Support Level
  • ARIS $23.28
  • LQDA $11.39
  • Resistance Level
  • ARIS $25.79
  • LQDA $11.91
  • Average True Range (ATR)
  • ARIS 1.18
  • LQDA 0.49
  • MACD
  • ARIS -0.20
  • LQDA 0.10
  • Stochastic Oscillator
  • ARIS 48.55
  • LQDA 89.72

About ARIS Aris Water Solutions Inc.

Aris Water Solutions Inc is an environmental infrastructure and solutions company that helps customers reduce their water and carbon footprints. It has two primary revenue streams. The Produced Water Handling business gathers, transports, and, unless recycled, handles produced water generated from oil and natural gas production. The Water Solutions business develops and operates recycling facilities to treat, store and recycle produced water.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: